Back
New Concept Energy Vs. Monopar Therapeutics Industry Stock Comparison
Sell
25
GBR
New Concept Energy
Last Price:
$0.94
Seasonality Move:
10.2%
Sell
31
MNPR
Monopar Therapeutics
Last Price:
$30.03
Seasonality Move:
-28.14%
Sell
25
New Concept Energy (GBR)
is a Sell
Is New Concept Energy a Buy, Sell or Hold?
-
The current New Concept Energy [GBR] share price is $0.94. The Score for GBR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
GBR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $30.90. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBR Stock Price Chart
What is New Concept Energy's stock price today?
-
The New Concept Energy share price today is $0.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBR is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
GBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 26.27 | Sell |
Chaikin Money Flow: | -7244 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.05 - 1.21) | Sell |
Bollinger Bands (100): | (1.12 - 1.22) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.4 | Sell |
Relative Strength Index (14 RSI): | 42.98 | Sell |
Chaikin Money Flow: | -11433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.47 - 47.63) | Sell |
Bollinger Bands (100): | (14.9 - 37.98) | Buy |
GBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.04 | Sell |
20-day SMA: | 1.1 | Sell |
50-day SMA: | 1.16 | Sell |
200-day SMA: | 1.28 | Sell |
8-day EMA: | 1.03 | Sell |
20-day EMA: | 1.09 | Sell |
50-day EMA: | 1.14 | Sell |
200-day EMA: | 1.2 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.14 | Sell |
20-day SMA: | 37.64 | Sell |
50-day SMA: | 34.67 | Sell |
200-day SMA: | 15.02 | Buy |
8-day EMA: | 31.33 | Sell |
20-day EMA: | 34.67 | Sell |
50-day EMA: | 33.62 | Sell |
200-day EMA: | 19.75 | Buy |
New Concept Energy Earnings Growth & GBR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
New Concept Energy Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |